| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600640120 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0022354915399913?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S0022354915399913?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 1133714 |
| P2093 | author name string | T. N. Tozer | |
| M. A. Gonzalez | |||
| T. T. Chang | |||
| P2860 | cites work | Salicylates and thyroid function. II. The effect on the thyroid-pituitary interrelation | Q33708922 |
| The relation between circulating and tissue concentrations of salicylate in the mouse in vivo | Q48887918 | ||
| The distribution of salicylate in mouse tissues after intraperitoneal injection. | Q51199159 | ||
| Blood-Brain and CSF Barriers to Penicillin and Related Organic Acids | Q51231399 | ||
| Red blood cell volume and distribution after bleed-out in the rat as determined by Cr 51-labeled red blood cells. | Q54270165 | ||
| Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man | Q69166774 | ||
| Determination of acetylsalicylic acid and salicylic acid in plasma | Q72243255 | ||
| Active transport of Diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood | Q78961689 | ||
| Journal of Pharmacology and Experimental Therapeutics | Q1500272 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Medical uses of salicylic acid | Q28453506 |
| pharmaceutical science | Q7180763 | ||
| salicylic acid | Q193572 | ||
| P304 | page(s) | 99-103 | |
| P577 | publication date | 1975-01-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Nonliner tissue disposition: salicylic acid in rat brain | |
| Nonlinear Tissue Disposition: Salicylic Acid in Rat Brain | |||
| P478 | volume | 64 |
| Q40437579 | Are interspecies comparisons in the toxicity of centrally acting drugs valid without brain concentrations? A commentary |
| Q73934608 | Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists |
| Q44942290 | Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog. |
| Q48247966 | Distribution Characteristics of Ethosuximide in Discrete Areas of Rat Brain |
| Q70978465 | Distribution, Metabolism, and Elimination of Phenobarbital in Rats: Physiologically Based Pharmacokinetic Model |
| Q44804450 | Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance |
| Q54036681 | In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain. |
| Q41286250 | Kinetics and brain uptake of S 9795, a new xanthine derivate, in rats |
| Q69375811 | Mode of action of tiaspirone on the central cholinergic system |
| Q44123294 | Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid |
| Q44256898 | Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits |
| Q72078537 | Pharmacological studies in the rat with [2-(1,3-didecanoyloxy)-propyl]2-acetyloxybenzoate (A-45474): an aspirin pro-drug with negligible gastric irritation |
| Q48434038 | Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation |
Search more.